Browse EV MemProt Atlas
Supporting publications (n)
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
EVMP confidence score
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| FCG2B | P31994 | Low affinity immunoglobulin gamma Fc region receptor II-b (IgG Fc receptor II-b) (CDw32) (Fc-gamma RII-b) (Fc-gamma-RIIb) (FcRII-b) (CD antigen CD32) | Cancer-related genesCD markersDisease related genes | 1 | Autoimmune diseaseB-cell lymphomaDiabetes mellitus | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.25 | ||
| FCG3A | P08637 | Low affinity immunoglobulin gamma Fc region receptor III-A (IgG Fc receptor III-A) (CD16-II) (CD16a antigen) (Fc-gamma RIII-alpha) (Fc-gamma RIII) (Fc-gamma RIIIa) (FcRIII) (FcRIIIa) (FcgammaRIIIA) (FcR-10) (IgG Fc receptor III-2) (CD antigen CD16a) | CD markersDisease related genesFDA approved drug targets | 1 | Hodgkin lymphomaLymphomaMature T-cell lymphoma | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.25 | ||
| FCGRN | P55899 | IgG receptor FcRn large subunit p51 (FcRn) (IgG Fc fragment receptor transporter alpha chain) (Neonatal Fc receptor) | FDA approved drug targetsPredicted intracellular proteinsPredicted membrane proteins | 1 | Acquired haemolytic anaemiaIdiopathic inflammatory myopathyInflammatory polyneuropathy | Clinical-translation mediationFusion and delivery mediation | 1 | 0.25 | ||
| FCRL3 | Q96P31 | Fc receptor-like protein 3 (FcR-like protein 3) (FcRL3) (Fc receptor homolog 3) (FcRH3) (IFGP family protein 3) (hIFGP3) (Immune receptor translocation-associated protein 3) (MAIA) (SH2 domain-containing phosphatase anchor protein 2) (CD antigen CD307c) | CD markersDisease related genesPredicted intracellular proteins | 1 | Fusion and delivery mediationImmune mediationReceptor-signaling mediation | 1 | 0.25 | |||
| FGFR1 | P11362 | Fibroblast growth factor receptor 1 (FGFR-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (BFGFR) (bFGF-R-1) (Fms-like tyrosine kinase 2) (FLT-2) (N-sam) (Proto-oncogene c-Fgr) (CD antigen CD331) | Cancer-related genesCD markersDisease related genes | 1 | Acute diabete complicationAcute myeloid leukaemiaAlzheimer disease | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.25 | ||
| FGFR2 | P21802 | Fibroblast growth factor receptor 2 (FGFR-2) (EC 2.7.10.1) (K-sam) (KGFR) (Keratinocyte growth factor receptor) (CD antigen CD332) | Cancer-related genesCD markersDisease related genes | 1 | Alzheimer diseaseBladder cancerBreast cancer | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.25 | ||
| FGRL1 | Q8N441 | Fibroblast growth factor receptor-like 1 (FGF receptor-like protein 1) (FGF homologous factor receptor) (FGFR-like protein) (Fibroblast growth factor receptor 5) (FGFR-5) | Human disease related genesPredicted intracellular proteinsPredicted membrane proteins | 1 | Adhesion and uptake mediationFusion and delivery mediationReceptor-signaling mediation | 1 | 0.25 | |||
| FLRT1 | Q9NZU1 | Leucine-rich repeat transmembrane protein FLRT1 (Fibronectin-like domain-containing leucine-rich transmembrane protein 1) | Predicted membrane proteins | 1 | Adhesion and uptake mediationReceptor-signaling mediation | 1 | 0.25 | |||
| FLRT2 | O43155 | Leucine-rich repeat transmembrane protein FLRT2 (Fibronectin-like domain-containing leucine-rich transmembrane protein 2) | 1 | Adhesion and uptake mediationReceptor-signaling mediation | 1 | 0.25 | ||||
| FREM2 | Q5SZK8 | FRAS1-related extracellular matrix protein 2 (ECM3 homolog) | Disease related genesHuman disease related genesPredicted membrane proteins | 1 | Other mediation | 1 | 0.25 | |||
| GP132 | Q9UNW8 | Probable G-protein coupled receptor 132 (G2 accumulation protein) | G-protein coupled receptorsPredicted intracellular proteinsPredicted membrane proteins | 7 | Receptor-signaling mediation | 1 | 0.25 | |||
| GPM6B | Q13491 | Neuronal membrane glycoprotein M6-b (M6b) | Predicted membrane proteins | 4 | Adhesion and uptake mediationFusion and delivery mediation | 1 | 0.25 | |||
| GPR39 | O43194 | G-protein coupled receptor 39 | G-protein coupled receptorsPredicted membrane proteinsTransporters | 7 | Acute diabete complication | Clinical-translation mediationReceptor-signaling mediation | 1 | 0.25 | ||
| GRIA2 | P42262 | Glutamate receptor 2 (GluR-2) (AMPA-selective glutamate receptor 2) (GluR-B) (GluR-K2) (Glutamate receptor ionotropic, AMPA 2) | Disease related genesHuman disease related genesPotential drug targets | 3 | NeuropathyParkinsonism | Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation | 1 | 0.25 | ||
| GRID1 | Q9ULK0 | Glutamate receptor ionotropic, delta-1 (GluD1) (GluR delta-1 subunit) | 3 | Clinical-translation mediationReceptor-signaling mediation | 1 | 0.25 | ||||
| HECAM | Q14CZ8 | Hepatic and glial cell adhesion molecule (glialCAM) (Hepatocyte cell adhesion molecule) (Protein hepaCAM) | Disease related genesHuman disease related genesPotential drug targets | 1 | Adhesion and uptake mediation | 1 | 0.25 | |||
| HLAC | P10321 | HLA class I histocompatibility antigen, C alpha chain (HLA-C) (HLA-Cw) (Human leukocyte antigen C) | 1 | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.25 | ||||
| HLAF | P30511 | HLA class I histocompatibility antigen, alpha chain F (CDA12) (HLA F antigen) (Leukocyte antigen F) (MHC class I antigen F) | 1 | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.25 | ||||
| IGSF8 | Q969P0 | Immunoglobulin superfamily member 8 (IgSF8) (CD81 partner 3) (Glu-Trp-Ile EWI motif-containing protein 2) (EWI-2) (Keratinocytes-associated transmembrane protein 4) (KCT-4) (LIR-D1) (Prostaglandin regulatory-like protein) (PGRL) (CD antigen CD316) | CD markersPredicted intracellular proteinsPredicted membrane proteins | 1 | Other mediation | 1 | 0.25 | |||
| IL1R2 | P27930 | Interleukin-1 receptor type 2 (IL-1R-2) (IL-1RT-2) (IL-1RT2) (CD121 antigen-like family member B) (CDw121b) (IL-1 type II receptor) (Interleukin-1 receptor beta) (IL-1R-beta) (Interleukin-1 receptor type II) (CD antigen CD121b) [Cleaved into: Interleukin-1 receptor type 2, membrane form (mIL-1R2) (mIL-1RII); Interleukin-1 receptor type 2, soluble form (sIL-1R2) (sIL-1RII)] | Cancer-related genesCD markersPlasma proteins | 1 | Immune system diseaseRheumatoid arthritis | Clinical-translation mediationImmune mediationMetabolism mediation | 1 | 0.25 | ||
| IL2RB | P14784 | Interleukin-2 receptor subunit beta (IL-2 receptor subunit beta) (IL-2R subunit beta) (IL-2RB) (High affinity IL-2 receptor subunit beta) (Interleukin-15 receptor subunit beta) (p70-75) (p75) (CD antigen CD122) | Cancer-related genesCD markersDisease related genes | 1 | Bladder cancerBrain cancerColorectal cancer | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.25 | ||
| IL3RA | P26951 | Interleukin-3 receptor subunit alpha (IL-3 receptor subunit alpha) (IL-3R subunit alpha) (IL-3R-alpha) (IL-3RA) (CD antigen CD123) | CD markersFDA approved drug targetsPredicted intracellular proteins | 1 | Acute myeloid leukaemiaAsthmaB-cell lymphoma | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.25 | ||
| ITA6 | P23229 | Integrin alpha-6 (CD49 antigen-like family member F) (VLA-6) (CD antigen CD49f) [Cleaved into: Integrin alpha-6 heavy chain; Integrin alpha-6 light chain; Processed integrin alpha-6 (Alpha6p)] | Cancer-related genesCD markersDisease related genes | 1 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 1 | 0.25 | |||
| ITAM | P11215 | Integrin alpha-M (CD11 antigen-like family member B) (CR-3 alpha chain) (Cell surface glycoprotein MAC-1 subunit alpha) (Leukocyte adhesion receptor MO1) (Neutrophil adherence receptor) (CD antigen CD11b) | Cancer-related genesCD markersDisease related genes | 1 | Pancreatic cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.25 | ||
| ITAV | P06756 | Integrin alpha-V (Vitronectin receptor) (Vitronectin receptor subunit alpha) (CD antigen CD51) [Cleaved into: Integrin alpha-V heavy chain; Integrin alpha-V light chain] | Cancer-related genesCD markersFDA approved drug targets | 1 | Colorectal cancerSolid tumour/cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.25 |